Virtual Medicinal Product (VMP)
-
Lacosamide 50mg tablets
Name Details
Current Name
Lacosamide 50mg tablets
|
Start Date
02-10-2008
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N03AX18
BNF |
Current BNF
04080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04080100
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42130411000001105 |
04-08-2023 |
|
442041004 |
22-10-2009 |
03-08-2023 |
14203711000001105 |
02-10-2008 |
21-10-2009 |
VMP Ingredients
VMP ingredients table
Lacosamide |
Based on Ingredient Substance |
|
50 mg |
|
Name
Lacosamide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
Parent Products
-
VTM
Lacosamide
-
VMP
(Current) Lacosamide 50mg tablets
Virtual Medicinal Product Pack (VMPP) Information